T-Cell-Immunity-Based Inhibitory Effects of Orally Administered Herbal Medicine Juzen-taiho-to on the Growth of Primarily Developed Melanocytic Tumors in RET-Transgenic Mice
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 117 (3) , 694-701
- https://doi.org/10.1046/j.0022-202x.2001.01457.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Further Characterization of the Sho-saiko-to-Mediated Anti-Tumor Effect on Melanoma Developed in RET-Transgenic MiceJournal of Investigative Dermatology, 2000
- Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse linesOncogene, 1999
- HPLC Analysis of Juzen-taiho-to and Its Variant Formulations and Their Antimetastatic Efficacies.CHEMICAL & PHARMACEUTICAL BULLETIN, 1999
- Transgenic mouse model for skin malignant melanomaOncogene, 1998
- Inhibitory Effect of a Traditional Chinese Medicine, Juzen‐taiho‐to, on Progressive Growth of Weakly Malignant Clone Cells Derived from Murine FibrosarcomaJapanese Journal of Cancer Research, 1996
- Spotaneous Melanocytosis in Transgenic MiceJournal of Investigative Dermatology, 1996
- Characterization of the Immunoregulatory Action of Saikosaponin-dCellular Immunology, 1994
- Characterization of in vitro IL‐2 production enhancing and anticomplementary pectic polysaccharides from kampo (Japanese herbal) medicine ‘Juzen‐Taiho‐To’Phytotherapy Research, 1993
- Bidirectional control by glycyrrhizin of the growth response of lymphocytes stimulated through a receptor-bypassed pathwayImmunology Letters, 1992
- Characterization of Mitogenic Pectic Polysaccharides from Kampo (Japanese Herbal) Medicine “Juzen-Taiho-To”1Planta Medica, 1991